AdaptHealth (NASDAQ:AHCO – Get Free Report) and Cencora (NYSE:COR – Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, dividends, risk, institutional ownership and valuation.
Risk and Volatility
AdaptHealth has a beta of 1.36, indicating that its share price is 36% more volatile than the S&P 500. Comparatively, Cencora has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500.
Profitability
This table compares AdaptHealth and Cencora’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| AdaptHealth | -12.90% | -0.27% | -0.09% |
| Cencora | 1.03% | 110.72% | 4.22% |
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| AdaptHealth | 1 | 1 | 7 | 0 | 2.67 |
| Cencora | 0 | 4 | 12 | 0 | 2.75 |
AdaptHealth presently has a consensus price target of $9.43, indicating a potential upside of 22.07%. Cencora has a consensus price target of $368.14, indicating a potential upside of 3.13%. Given AdaptHealth’s higher probable upside, research analysts clearly believe AdaptHealth is more favorable than Cencora.
Valuation and Earnings
This table compares AdaptHealth and Cencora”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| AdaptHealth | $3.24 billion | 0.32 | -$70.79 million | ($3.00) | -2.57 |
| Cencora | $638.56 million | 106.67 | $3.48 billion | $17.92 | 19.92 |
Cencora has lower revenue, but higher earnings than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
82.7% of AdaptHealth shares are owned by institutional investors. Comparatively, 97.5% of Cencora shares are owned by institutional investors. 1.9% of AdaptHealth shares are owned by insiders. Comparatively, 0.4% of Cencora shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Summary
Cencora beats AdaptHealth on 10 of the 14 factors compared between the two stocks.
About AdaptHealth
AdaptHealth provides home medical equipment, supplies and related services to patients managing chronic conditions and recovering from illness or injury. Its offerings include oxygen and other respiratory equipment, sleep-therapy devices such as CPAP machines, and diabetes supplies, including continuous glucose monitoring products. The company also provides equipment and support for other care needs at home, working with patients, clinicians, hospitals and health plans to help coordinate access to prescribed products and services.
About Cencora
Cencora, formerly known as AmerisourceBergen, is a global pharmaceutical services company that connects pharmaceutical manufacturers with healthcare providers. Its core business includes sourcing and distributing medicines and other healthcare products to pharmacies, hospitals, health systems and other care providers. The company also provides services supporting specialty pharmaceuticals, including logistics, consulting and solutions for manufacturers and healthcare organizations. These services help manage the handling and delivery of complex medicines and support access to treatments.
Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.
